Literature DB >> 25548762

Case series of precursor B-cell lymphoblastic lymphoma.

Jin Yong Kim1, Sang Yong Om1, Su-Jin Shin2, Jeong Eun Kim3, Dok Hyun Yoon3, Cheolwon Suh3.   

Abstract

Precursor B-cell lymphoblastic lymphoma (B-LBL) is an uncommon subtype of Non-Hodgkin lymphoma (NHL), accounting for only 0.3% of NHL in adults and less than 10% of all LBL cases. Unlike T-cell LBL, it usually presents with extranodal involvement while sparing the bone marrow (BM). Among the 27 patients with LBL treated in the Asan Medical Center between January 2007 and March 2012, 3 had B-LBL. All had a good performance status and low International Prognostic Index. However, unlike most previously reported cases, the patients had lymphoma in their bone marrow and extranodal sites such as bone and lung. After intensive combination chemotherapy, one patient achieved a complete response and the other 2 patients, a partial response. Our experience suggests that multiple extranodal sites may be involved in B-LBL and BM involvement may not be as infrequent as previously thought. Furthermore, intensive chemotherapy seems to be effective.

Entities:  

Keywords:  B-cell lymphoblastic lymphoma; Bone marrow involvement; Chemotherapy

Year:  2014        PMID: 25548762      PMCID: PMC4278010          DOI: 10.5045/br.2014.49.4.270

Source DB:  PubMed          Journal:  Blood Res        ISSN: 2287-979X


  13 in total

1.  Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report.

Authors:  A Reiter; M Schrappe; W D Ludwig; M Tiemann; R Parwaresch; M Zimmermann; E Schirg; G Henze; G Schellong; H Gadner; H Riehm
Journal:  Blood       Date:  2000-01-15       Impact factor: 22.113

Review 2.  Lymphoblastic lymphoma.

Authors:  Sergio Cortelazzo; Maurilio Ponzoni; Andrés J M Ferreri; Dieter Hoelzer
Journal:  Crit Rev Oncol Hematol       Date:  2011-01-26       Impact factor: 6.312

3.  MIC2, TdT, bcl-2, and CD34 expression in paraffin-embedded high-grade lymphoma/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities.

Authors:  R A Soslow; V Bhargava; R A Warnke
Journal:  Hum Pathol       Date:  1997-10       Impact factor: 3.466

4.  High-dose Ara-C for remission induction and consolidation of previously untreated adults with ALL or lymphoblastic lymphoma.

Authors:  R Willemze; J M Zijlmans; G J den Ottolander; J C Kluin-Nelemans; J H Falkenburg; C W Starrenburg; J F van der Burgh; W E Fibbe
Journal:  Ann Hematol       Date:  1995-02       Impact factor: 3.673

Review 5.  Precursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and bone marrow involvement and review of the literature.

Authors:  A Maitra; R W McKenna; A G Weinberg; N R Schneider; S H Kroft
Journal:  Am J Clin Pathol       Date:  2001-06       Impact factor: 2.493

6.  Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement.

Authors:  P Lin; D Jones; D M Dorfman; L J Medeiros
Journal:  Am J Surg Pathol       Date:  2000-11       Impact factor: 6.394

7.  B-lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology.

Authors:  R A Soslow; R N Baergen; R A Warnke
Journal:  Cancer       Date:  1999-06-15       Impact factor: 6.860

Review 8.  Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia.

Authors:  C H Pui; F G Behm; W M Crist
Journal:  Blood       Date:  1993-07-15       Impact factor: 22.113

9.  Clinical features and treatment outcomes of adult B- and T-lymphoblastic lymphoma: results of multicentre analysis in Korea.

Authors:  Myung Hee Chang; Seok Jin Kim; Kihyun Kim; Sung Yong Oh; Dae Ho Lee; Jooryung Huh; Young Hyeh Ko; Chul Won Choi; Deok-Hwan Yang; Jong Ho Won; Won Seog Kim; Cheolwon Suh
Journal:  Leuk Lymphoma       Date:  2009-07

10.  Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report.

Authors:  C A Linker; L J Levitt; M O'Donnell; S J Forman; C A Ries
Journal:  Blood       Date:  1991-12-01       Impact factor: 22.113

View more
  1 in total

1.  A Rare Presentation of Precursor B-cell Lymphoblastic Lymphoma in a Child.

Authors:  Zarmina Javed; Faiza Hanif
Journal:  Cureus       Date:  2018-08-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.